Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
11.51
+0.02 (0.17%)
At close: Apr 28, 2026, 4:00 PM EDT
11.51
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Perrigo Company Revenue
In the year 2025, Perrigo Company had annual revenue of $4.25B, down -2.75%. Perrigo Company had revenue of $1.11B in the quarter ending December 31, 2025, a decrease of -2.52%.
Revenue (ttm)
$4.25B
Revenue Growth
-2.75%
P/S Ratio
0.37
Revenue / Employee
$525,074
Employees
8,100
Market Cap
1.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.25B | -120.30M | -2.75% |
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.27B |
| Phibro Animal Health | 1.46B |
| Evotec SE | 925.65M |
| ANI Pharmaceuticals | 883.37M |
| BioCryst Pharmaceuticals | 874.84M |
| Collegium Pharmaceutical | 780.57M |
| Pacira BioSciences | 726.41M |
| Alvotech | 588.90M |
PRGO News
- 6 days ago - Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026 - PRNewsWire
- 6 weeks ago - Perrigo Company Transcript: UBS Global Consumer and Retail Conference - Transcripts
- 7 weeks ago - 8 Stocks to Buy as Merger-Mania Takes Over - Benzinga
- 7 weeks ago - 5 Small Caps With Yields Up To 11% That Punch Like Heavyweights - Forbes
- 2 months ago - Perrigo to Present at the UBS Global Consumer and Retail Conference - PRNewsWire
- 2 months ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
- 2 months ago - Perrigo Company Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations - PRNewsWire